Woman of Distinction - Signature Luncheon
Join us for our Annual Woman of Distinction Signature Luncheon on November 9th at the Westin with Keynote Speaker Lauren Bricks, CEO and Co-Founder of Ipsum Diagnostics.
The Sandy Springs Perimeter Chamber would like to welcome Lauren Spanjer Bricks, CEO and Co-Founder of Ipsum Diagnostics, as our Keynote Speaker.
About our Keynote Speaker:
Sandy Springs native Lauren Spanjer Bricks is at the forefront of lifesaving COVID-19 testing. Lauren is the co-founder and CEO of Ipsum Diagnostics, an independent, CAP accredited, clinical and anatomical pathology testing laboratory. By the end of 2019, Lauren recognized that the existing molecular Polymerase Chain Reaction (PCR) technology used to identify the presence of SARS-CoV-2, the virus that causes COVID-19 infection, was being conducted on relatively inefficient PCR instruments typically used for research. The only tests that were available required too much time and could process only 96 patient samples at a time. She knew the answer for increasing COVID-19 testing capacity nationally was to develop tests that utilized faster instruments. Her goal, to process four times the number of patient samples (384) at a time, was ambitious. But if she could develop this test and receive an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA), she could share the proprietary protocols with other laboratories and immediately boost national COVID-19 testing capacity.
Beginning in January 2020, Lauren guided the company in the development of an accurate and high capacity COVID-19 PCR test that satisfied the criteria for issuance of an EUA from the FDA. The EUA was granted on April 1, 2020.
- January 2020 – Lauren had the foresight and vision to apply to the National Institutes of Health/National Institute of Allergy and Infectious Diseases division to receive the materials needed for the development of tests that could provide accurate PCR results.
- April 1, 2020 – Ipsum received Emergency Use Authorization for its COV-19 IDx SARS CoV-2 RT PCR Laboratory Developed Test.
- Ipsum was the first lab in Georgia to receive an EUA from the FDA for COVID-19 testing and first lab in the country to develop a high-complexity COVID-19 PCR Test, known now as gold standard in COVID testing.
- It was one of the first 12 labs in the country (out of 200) to receive an EUA from the FDA for COVID-19 PCR testing.
- April 8, 2020 - Georgia Gov. Brian Kemp announced a partnership between Ipsum and the Georgia Department of Public Health to provide critical COVID-19 testing for the state.
- With Lauren leading Ipsum, the state of Georgia went from being ranked 45th in the country to 9th in the country for COVID-19 testing capabilities in a matter of two months.
- In just under a year, Ipsum reported over 1.2 million COVID-19 PCR patient test results that impacted hundreds of thousands of lives around the state of Georgia.
- Ipsum was the first COVID-19 testing facility to provide patients the option to use a Spanish language patient portal with reports in Spanish, and the first lab in the state of Georgia to provide test result reports of any kind in a language other than English.
Prior to starting Ipsum, Lauren worked for the Biological Defense Research Directorate at the Navy Medical Research Center in Silver Spring, Maryland, where she was awarded the Civilian of the Quarter award for her work on biowarfare assay development. Lauren gained extensive expertise in laboratory regulatory requirements while working in Thermo Fisher Scientific’s medical, research and forensic laboratories. She worked closely with experts at every level, ranging from technicians to lab directors, to ensure the successful implementation of instruments, assays, Laboratory Information Management System (LIMS) development and inspection preparations.
Immediately prior to founding Ipsum, Lauren worked as a National Field Operations Manager at eLab Solutions, an Atlanta-based software solutions company and Clinical Chemistry and Toxicology Lab, where she focused on tailoring lab setups to meet client needs. She was intimately involved in setting up numerous labs across the United States, from technical requirements to staffing, validation, and standard operating procedure development, with one lab-client she served earning the Laboratory of the Year award from COLA.
As the co-owner and leader of Ipsum Diagnostics, Lauren’s knowledge of complex and rigorous laboratory regulations and her extensive background in emerging technologies and PCR test development distinguishes the company within the molecular diagnostic field. It is unusual to find an owner and CEO of a laboratory who has vast experience in both life and clinical sciences. Most laboratory owners are experienced in business but are unfamiliar with the complexity of laboratory science.
Lauren holds a Bachelor’s degree in biology and an MBA from the University of Maryland. She has lived in Atlanta most of her life